Med-X is gearing up for a possible NASDAQ listing

(ticker: MXRX)

January 14, 2026


*together with Med-x Inc

Med-X is gearing up for a possible NASDAQ listing (ticker: MXRX). But the real opportunity is now – before public health adoption accelerates.

In certain use cases, Med-X's all-natural pesticides have outperformed chemical brands in independent lab tests, delivering safer solutions without sacrificing results.

Now, Med-X is approaching a major real-world validation catalyst: Florida Mosquito Control Districts are independently testing Nature-Cide as an adulticide, larvicide, and barrier treatment – with the goal of adding it to their official rotation.

Florida has the most well-funded mosquito control districts in the United States and carries the highest responsibility for controlling mosquito-borne threats. These districts are known as leaders and innovators in Integrated Mosquito Management – meaning that when Florida adopts a solution, other regions often follow.

And right now, these districts need better options.

Public scrutiny over the chemical pesticides traditionally used in mosquito control is rising fast – especially around communities, schools, and waterways. Nature-Cide's plant-based approach offers a potential alternative that aligns with performance demands while reducing toxicity concerns.

Med-X has earned national and international recognition for providing effective alternatives to conventional pesticides across residential, commercial, and agricultural sectors. Proudly produced in the USA under strict quality standards, Nature-Cide reflects their commitment to sustainable pest management innovation.

With $6.4M in sales in just four years, expanding into 41 international markets, Med-X is getting ready for the next step...

Simpler. Safer. More Effective Pesticides.

Disclosures

This is a paid advertisement for Med-X's Regulation A+ Offering.
Please read the offering circular at invest.medx-rx.com 

DISCLAIMER: This entity is owned by Sherwood Ventures LLC (SV). Full disclaimer https://bullseyealerts.com/disclaimer/. We are a financial publisher, not a registered investment advisor. Our content is for informational purposes only and should not be considered personalized investment advice. All trading involves substantial risk of loss and you may lose some or all of your invested capital. Past performance does not guarantee future results.

*PAID PROMOTION: Sherwood Ventures (SV) has been paid two thousand four hundred fifty dollars by Med-x Inc (via IMS) to increase public awareness of the company. SV owners are not currently invested in this company.  We recommend that you do your own independent research before investing in anything, as private investing is risky and often illiquid. We believe in the companies we form affiliate relationships with, but please don’t invest any money unless you believe it will help you achieve your goals. SV is not responsible for any content hosted on third-party sites or your experience with third-party advertisers. It is the third party's responsibility to ensure compliance with applicable laws. We make no guarantees or warranties about what is advertised and have no fiduciary duty to subscribers. Always consult a qualified financial professional before making investment decisions.